MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research note published on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Up 1.1 % NASDAQ MNOV opened at $1.87 on Friday. The stock’s 50-day simple moving average is $2.06 and its two-hundred day simple moving […]

Leave a Reply

Your email address will not be published.

Previous post Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by Analysts at StockNews.com
Next post Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated at StockNews.com